FDA wants suicide warning on antidepressants
The Food and Drug Administration has proposed changes in labelling of antidepressants in order to warn people taking them that they may increase suicidal thoughts. They propose the labelling be on the bottles for 18 to 24 year old adults during their first month or two of treatment. This recommendation is based on a Journal of the American Medical Association study.
The Washington Post added that the proposal would affect labelling of all antidepressants.
The facts from the study used to support the proposal was a good element in these stories.